Details for: NRXN3
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 56.13rCSI 67.05%PRS 97.19
-
CSI 55.84rCSI 82.08%PRS 97.62
-
CSI 54.38rCSI 67.65%PRS 96.84
-
CSI 50.61rCSI 65.25%PRS 97.55
-
CSI 47.9rCSI 89.71%PRS 97.43
-
CSI 42.12rCSI 84.57%PRS 98.22
-
CSI 41.32rCSI 95.37%PRS 97.29
-
CSI 39.5rCSI 63.53%PRS 97.04
-
CSI 35.62rCSI 48.74%PRS 97.67
-
CSI 34.34rCSI 57.64%PRS 97.56
-
CSI 31.11rCSI 54.94%PRS 97.31
-
CSI 30.36rCSI 79.09%PRS 96.85
-
CSI 30.2rCSI 65.52%PRS 95.4
-
CSI 29.73rCSI 79.17%PRS 95.22
-
CSI 29.11rCSI 23.01%PRS 98.76
-
CSI 29.04rCSI 47.56%PRS 97.95
-
CSI 28.2rCSI 67.45%PRS 96.2
-
CSI 27.7rCSI 100%PRS 95.28
-
CSI 27.42rCSI 35.2%PRS 97.88
-
CSI 27.26rCSI 87.23%PRS 98.93
-
CSI 25.29rCSI 61.46%PRS 96.29
-
CSI 22.08rCSI 39.67%PRS 97.92
-
CSI 21.84rCSI 39.68%PRS 97.58
-
CSI 21.1rCSI 36.5%PRS 98.18
-
CSI 20.78rCSI 64.99%PRS 97.54
-
CSI 20.76rCSI 42.66%PRS 95.25
-
CSI 20.33rCSI 15.06%PRS 98.58
-
CSI 20.33rCSI 60.08%PRS 96.04
-
CSI 20.29rCSI 66.67%PRS 95.78
-
CSI 19.69rCSI 43.32%PRS 93.48
-
CSI 18.97rCSI 54.97%PRS 97.22
-
CSI 18.94rCSI 33.21%PRS 98.28
-
CSI 18.75rCSI 58.61%PRS 97.18
-
CSI 18.46rCSI 29.44%PRS 97.73
-
CSI 17.18rCSI 61.83%PRS 96.67
-
CSI 17.12rCSI 48.66%PRS 98.29
-
CSI 17rCSI 46.85%PRS 98.98
-
CSI 16.67rCSI 42.86%PRS 97.99
-
CSI 16.43rCSI 26.44%PRS 97.33
-
CSI 15.96rCSI 100%PRS 92.67
-
CSI 15.77rCSI 24.08%PRS 98.99
-
CSI 15.75rCSI 59.52%PRS 96.66
-
CSI 15.62rCSI 24.84%PRS 98.12
-
CSI 15.59rCSI 61.75%PRS 96.95
-
CSI 15.5rCSI 51.92%PRS 95.1
-
CSI 15.28rCSI 68.24%PRS 94.47
-
CSI 15.21rCSI 23.6%PRS 99.13
-
CSI 15rCSI 70.56%PRS 95.11
-
CSI 14.95rCSI 19.19%PRS 98.43
-
CSI 14.78rCSI 60.23%PRS 96.88
-
CSI 14.74rCSI 32.57%PRS 97.12
-
CSI 14.62rCSI 12.86%PRS 97.45
-
CSI 14.48rCSI 35.83%PRS 99.57
-
CSI 14.42rCSI 35.22%PRS 97.5
-
CSI 13.96rCSI 78.91%PRS 96.37
-
CSI 13.56rCSI 71.32%PRS 95.24
-
CSI 13.52rCSI 19.3%PRS 99.36
-
CSI 13.18rCSI 30.08%PRS 97.89
-
CSI 12.8rCSI 47.94%PRS 98.93
-
CSI 12.75rCSI 11.86%PRS 99.64
-
CSI 12.5rCSI 54.91%PRS 98.02
-
CSI 12.43rCSI 42.59%PRS 95.53
-
CSI 11.89rCSI 13.73%PRS 97.73
-
CSI 11.83rCSI 20.87%PRS 99.48
-
CSI 11.83rCSI 26.52%PRS 97.34
-
CSI 11.67rCSI 58.02%PRS 97.27
-
CSI 11.66rCSI 61.28%PRS 98.97
-
CSI 11.42rCSI 23.17%PRS 95.13
-
CSI 11.35rCSI 50.45%PRS 99.02
-
CSI 11.08rCSI 53.02%PRS 98.65
-
CSI 11.03rCSI 65.15%PRS 95.74
-
CSI 10.85rCSI 15.38%PRS 98.88
-
CSI 10.82rCSI 45.99%PRS 97.58
-
CSI 10.68rCSI 70.86%PRS 96.2
-
CSI 10.34rCSI 60.91%PRS 96.73
-
CSI 10.31rCSI 42.83%PRS 97.82
-
CSI 10.14rCSI 9.78%PRS 99.07
-
CSI 10.09rCSI 7.82%PRS 99.66
-
CSI 10.04rCSI 71.77%PRS 95.55
-
CSI 9.89rCSI 67.33%PRS 95.93
-
CSI 9.87rCSI 29.15%PRS 99.2
-
CSI 9.77rCSI 26.12%PRS 98.51
-
CSI 9.59rCSI 13.11%PRS 98.3
-
CSI 9.53rCSI 28.27%PRS 99.79
-
CSI 9.42rCSI 35.86%PRS 97.31
-
CSI 9.41rCSI 70.72%PRS 94.93
-
CSI 9.38rCSI 16.53%PRS 97.94
-
CSI 9.14rCSI 70.84%PRS 95.88
-
CSI 9.01rCSI 64.33%PRS 97.53
-
CSI 8.24rCSI 9.53%PRS 98.1
-
CSI 8.1rCSI 59.56%PRS 97.57
-
CSI 7.93rCSI 10.6%PRS 99.39
-
CSI 7.91rCSI 32.24%PRS 99.39
-
CSI 7.85rCSI 66.06%PRS 94.23
-
CSI 7.74rCSI 17.64%PRS 97.25
-
CSI 7.73rCSI 68.07%PRS 95.14
-
CSI 7.65rCSI 33.66%PRS 95.54
-
CSI 7.48rCSI 64.44%PRS 97.05
-
CSI 7.43rCSI 35.6%PRS 99.44
-
CSI 7.16rCSI 41.26%PRS 98.6
-
CSI 1.7rCSI 3.2%PRS 99.0%
-
CSI 2.0rCSI 26.1%PRS 97.2%
-
CSI 2.5rCSI 59.3%PRS 95.5%
-
CSI 2.5rCSI 59.6%PRS 95.7%
-
CSI 2.7rCSI 54.7%PRS 96.8%
-
CSI 2.7rCSI 7.7%PRS 99.2%
-
CSI 2.7rCSI 55.2%PRS 96.7%
-
CSI 2.7rCSI 4.8%PRS 88.4%
-
CSI 2.8rCSI 70.1%PRS 100.0%
-
CSI 2.9rCSI 20.3%PRS 98.6%
-
CSI 2.9rCSI 18.7%PRS 96.8%
-
CSI 3.7rCSI 23.4%PRS 99.5%
-
CSI 3.9rCSI 10.4%PRS 99.6%
-
CSI 4.0rCSI 56.1%PRS 96.7%
-
CSI 4.0rCSI 8.0%PRS 98.3%
-
CSI 4.5rCSI 14.5%PRS 98.1%
-
CSI 4.6rCSI 7.5%PRS 90.4%
-
CSI 4.8rCSI 11.4%PRS 99.2%
-
CSI 4.8rCSI 6.2%PRS 99.6%
-
CSI 4.9rCSI 50.7%PRS 97.1%
-
CSI 5.0rCSI 40.2%PRS 99.1%
-
CSI 5.1rCSI 53.8%PRS 98.2%
-
CSI 5.6rCSI 8.3%PRS 98.4%
-
CSI 5.7rCSI 14.7%PRS 99.0%
-
CSI 5.7rCSI 65.5%PRS 93.5%
-
CSI 6.0rCSI 9.2%PRS 98.7%
-
CSI 6.0rCSI 4.9%PRS 99.3%
-
CSI 6.0rCSI 19.6%PRS 98.4%
-
CSI 6.1rCSI 8.7%PRS 97.4%
-
CSI 6.7rCSI 57.8%PRS 98.0%
-
CSI 6.8rCSI 10.3%PRS 98.5%
-
CSI 6.8rCSI 67.8%PRS 83.9%
-
CSI 7.0rCSI 37.4%PRS 98.5%
-
CSI 7.1rCSI 44.5%PRS 97.7%
-
CSI 7.2rCSI 41.3%PRS 98.6%
-
CSI 7.4rCSI 35.6%PRS 99.4%
-
CSI 7.5rCSI 64.4%PRS 97.1%
-
CSI 7.7rCSI 33.7%PRS 95.5%
-
CSI 7.7rCSI 68.1%PRS 95.1%
-
CSI 7.7rCSI 17.6%PRS 97.3%
-
CSI 7.9rCSI 66.1%PRS 94.2%
-
CSI 7.9rCSI 32.2%PRS 99.4%
-
CSI 7.9rCSI 10.6%PRS 99.4%
-
CSI 8.1rCSI 59.6%PRS 97.6%
-
CSI 8.2rCSI 9.5%PRS 98.1%
-
CSI 9.0rCSI 64.3%PRS 97.5%
-
CSI 9.1rCSI 70.8%PRS 95.9%
-
CSI 9.4rCSI 16.5%PRS 97.9%
-
CSI 9.4rCSI 70.7%PRS 94.9%
-
CSI 9.4rCSI 35.9%PRS 97.3%
-
CSI 9.5rCSI 28.3%PRS 99.8%
-
CSI 9.6rCSI 13.1%PRS 98.3%
-
CSI 9.8rCSI 26.1%PRS 98.5%
-
CSI 9.9rCSI 29.2%PRS 99.2%
-
CSI 9.9rCSI 67.3%PRS 95.9%
-
CSI 10.0rCSI 71.8%PRS 95.6%
-
CSI 10.1rCSI 7.8%PRS 99.7%
-
CSI 10.1rCSI 9.8%PRS 99.1%
-
CSI 10.3rCSI 42.8%PRS 97.8%
-
CSI 10.3rCSI 60.9%PRS 96.7%
-
CSI 10.7rCSI 70.9%PRS 96.2%
-
CSI 10.8rCSI 46.0%PRS 97.6%
-
CSI 10.9rCSI 15.4%PRS 98.9%
-
CSI 11.0rCSI 65.2%PRS 95.7%
-
CSI 11.1rCSI 53.0%PRS 98.7%
-
CSI 11.4rCSI 50.5%PRS 99.0%
-
CSI 11.4rCSI 23.2%PRS 95.1%
-
CSI 11.7rCSI 61.3%PRS 99.0%
-
CSI 11.7rCSI 58.0%PRS 97.3%
-
CSI 11.8rCSI 26.5%PRS 97.3%
-
CSI 11.8rCSI 20.9%PRS 99.5%
-
CSI 11.9rCSI 13.7%PRS 97.7%
-
CSI 12.4rCSI 42.6%PRS 95.5%
-
CSI 12.5rCSI 54.9%PRS 98.0%
-
CSI 12.8rCSI 11.9%PRS 99.6%
-
CSI 12.8rCSI 47.9%PRS 98.9%
-
CSI 13.2rCSI 30.1%PRS 97.9%
-
CSI 13.5rCSI 19.3%PRS 99.4%
-
CSI 13.6rCSI 71.3%PRS 95.2%
-
CSI 14.0rCSI 78.9%PRS 96.4%
-
CSI 14.4rCSI 35.2%PRS 97.5%
-
CSI 14.5rCSI 35.8%PRS 99.6%
-
CSI 14.6rCSI 12.9%PRS 97.5%
-
CSI 14.7rCSI 32.6%PRS 97.1%
-
CSI 14.8rCSI 60.2%PRS 96.9%
-
CSI 15.0rCSI 19.2%PRS 98.4%
-
CSI 15.0rCSI 70.6%PRS 95.1%
-
CSI 15.2rCSI 23.6%PRS 99.1%
-
CSI 15.3rCSI 68.2%PRS 94.5%
-
CSI 15.5rCSI 51.9%PRS 95.1%
-
CSI 15.6rCSI 61.8%PRS 97.0%
-
CSI 15.6rCSI 24.8%PRS 98.1%
-
CSI 15.8rCSI 59.5%PRS 96.7%
-
CSI 15.8rCSI 24.1%PRS 99.0%
-
CSI 16.0rCSI 100.0%PRS 92.7%
-
CSI 16.4rCSI 26.4%PRS 97.3%
-
CSI 16.7rCSI 42.9%PRS 98.0%
-
CSI 17.0rCSI 46.9%PRS 99.0%
-
CSI 17.1rCSI 48.7%PRS 98.3%
-
CSI 17.2rCSI 61.8%PRS 96.7%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 3726732186
Symbol: NRX3A_HUMAN
Name: Neurexin-3
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 12379233
Title: Identification and characterization of heart-specific splicing of human neurexin 3 mRNA (NRXN3).
PubMed ID: 12379233
PubMed ID: 11944992
Title: Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity.
PubMed ID: 11944992
PubMed ID: 9872452
Title: Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.
PubMed ID: 9872452
PubMed ID: 12508121
Title: The DNA sequence and analysis of human chromosome 14.
PubMed ID: 12508121
DOI: 10.1038/nature01348
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 19926856
Title: The synaptic proteins neurexins and neuroligins are widely expressed in the vascular system and contribute to its functions.
PubMed ID: 19926856
Sequence Information:
- Length: 1643
- Mass: 180599
- Checksum: E7360348E263C6EC
- Sequence:
MSSTLHSVFF TLKVSILLGS LLGLCLGLEF MGLPNQWARY LRWDASTRSD LSFQFKTNVS TGLLLYLDDG GVCDFLCLSL VDGRVQLRFS MDCAETAVLS NKQVNDSSWH FLMVSRDRLR TVLMLDGEGQ SGELQPQRPY MDVVSDLFLG GVPTDIRPSA LTLDGVQAMP GFKGLILDLK YGNSEPRLLG SRGVQMDAEG PCGERPCENG GICFLLDGHP TCDCSTTGYG GKLCSEDVSQ DPGLSHLMMS EQAREENVAT FRGSEYLCYD LSQNPIQSSS DEITLSFKTW QRNGLILHTG KSADYVNLAL KDGAVSLVIN LGSGAFEAIV EPVNGKFNDN AWHDVKVTRN LRQVTISVDG ILTTTGYTQE DYTMLGSDDF FYVGGSPSTA DLPGSPVSNN FMGCLKEVVY KNNDIRLELS RLARIADTKM KIYGEVVFKC ENVATLDPIN FETPEAYISL PKWNTKRMGS ISFDFRTTEP NGLILFTHGK PQERKDARSQ KNTKVDFFAV ELLDGNLYLL LDMGSGTIKV KATQKKANDG EWYHVDIQRD GRSGTISVNS RRTPFTASGE SEILDLEGDM YLGGLPENRA GLILPTELWT AMLNYGYVGC IRDLFIDGRS KNIRQLAEMQ NAAGVKSSCS RMSAKQCDSY PCKNNAVCKD GWNRFICDCT GTGYWGRTCE REASILSYDG SMYMKIIMPM VMHTEAEDVS FRFMSQRAYG LLVATTSRDS ADTLRLELDG GRVKLMVNLD CIRINCNSSK GPETLYAGQK LNDNEWHTVR VVRRGKSLKL TVDDDVAEGT MVGDHTRLEF HNIETGIMTE KRYISVVPSS FIGHLQSLMF NGLLYIDLCK NGDIDYCELK ARFGLRNIIA DPVTFKTKSS YLSLATLQAY TSMHLFFQFK TTSPDGFILF NSGDGNDFIA VELVKGYIHY VFDLGNGPNV IKGNSDRPLN DNQWHNVVIT RDNSNTHSLK VDTKVVTQVI NGAKNLDLKG DLYMAGLAQG MYSNLPKLVA SRDGFQGCLA SVDLNGRLPD LINDALHRSG QIERGCEGPS TTCQEDSCAN QGVCMQQWEG FTCDCSMTSY SGNQCNDPGA TYIFGKSGGL ILYTWPANDR PSTRSDRLAV GFSTTVKDGI LVRIDSAPGL GDFLQLHIEQ GKIGVVFNIG TVDISIKEER TPVNDGKYHV VRFTRNGGNA TLQVDNWPVN EHYPTGRQLT IFNTQAQIAI GGKDKGRLFQ GQLSGLYYDG LKVLNMAAEN NPNIKINGSV RLVGEVPSIL GTTQTTSMPP EMSTTVMETT TTMATTTTRK NRSTASIQPT SDDLVSSAEC SSDDEDFVEC EPSTTGGELV IPLLVEDPLA TPPIATRAPS ITLPPTFRPL LTIIETTKDS LSMTSEAGLP CLSDQGSDGC DDDGLVISGY GSGETFDSNL PPTDDEDFYT TFSLVTDKSL STSIFEGGYK AHAPKWESKD FRPNKVSETS RTTTTSLSPE LIRFTASSSS GMVPKLPAGK MNNRDLKPQP DIVLLPLPTA YELDSTKLKS PLITSPMFRN VPTANPTEPG IRRVPGASEV IRESSSTTGM VVGIVAAAAL CILILLYAMY KYRNRDEGSY QVDETRNYIS NSAQSNGTLM KEKQQSSKSG HKKQKNKDRE YYV
Genular Protein ID: 4075755670
Symbol: NRX3B_HUMAN
Name: Neurexin-3-beta
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 12379233
Title: Identification and characterization of heart-specific splicing of human neurexin 3 mRNA (NRXN3).
PubMed ID: 12379233
PubMed ID: 11944992
Title: Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity.
PubMed ID: 11944992
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 17974005
Title: The full-ORF clone resource of the German cDNA consortium.
PubMed ID: 17974005
PubMed ID: 12508121
Title: The DNA sequence and analysis of human chromosome 14.
PubMed ID: 12508121
DOI: 10.1038/nature01348
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 19926856
Title: The synaptic proteins neurexins and neuroligins are widely expressed in the vascular system and contribute to its functions.
PubMed ID: 19926856
PubMed ID: 21084300
Title: Processing of the synaptic cell adhesion molecule neurexin-3beta by Alzheimer disease alpha- and gamma-secretases.
PubMed ID: 21084300
Sequence Information:
- Length: 637
- Mass: 69305
- Checksum: A0F100DA9D72A149
- Sequence:
MHLRIHARRS PPRRPAWTLG IWFLFWGCIV SSVWSSSNVA SSSSTSSSPG SHSQHEHHFH GSKHHSVPIS IYRSPVSLRG GHAGATYIFG KSGGLILYTW PANDRPSTRS DRLAVGFSTT VKDGILVRID SAPGLGDFLQ LHIEQGKIGV VFNIGTVDIS IKEERTPVND GKYHVVRFTR NGGNATLQVD NWPVNEHYPT GRQLTIFNTQ AQIAIGGKDK GRLFQGQLSG LYYDGLKVLN MAAENNPNIK INGSVRLVGE VPSILGTTQT TSMPPEMSTT VMETTTTMAT TTTRKNRSTA SIQPTSDDLV SSAECSSDDE DFVECEPSTG GELVIPLLVE DPLATPPIAT RAPSITLPPT FRPLLTIIET TKDSLSMTSE AGLPCLSDQG SDGCDDDGLV ISGYGSGETF DSNLPPTDDE DFYTTFSLVT DKSLSTSIFE GGYKAHAPKW ESKDFRPNKV SETSRTTTTS LSPELIRFTA SSSSGMVPKL PAGKMNNRDL KPQPDIVLLP LPTAYELDST KLKSPLITSP MFRNVPTANP TEPGIRRVPG ASEVIRESSS TTGMVVGIVA AAALCILILL YAMYKYRNRD EGSYQVDETR NYISNSAQSN GTLMKEKQQS SKSGHKKQKN KDREYYV
Genular Protein ID: 1992696126
Symbol: A0A0A0MR89_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 11237011
Title: Initial sequencing and analysis of the human genome.
PubMed ID: 11237011
DOI: 10.1038/35057062
PubMed ID: 12508121
Title: The DNA sequence and analysis of human chromosome 14.
PubMed ID: 12508121
DOI: 10.1038/nature01348
PubMed ID: 15496913
Title: Finishing the euchromatic sequence of the human genome.
PubMed ID: 15496913
DOI: 10.1038/nature03001
Sequence Information:
- Length: 1571
- Mass: 173660
- Checksum: 39ECDE34CF41CD27
- Sequence:
MSSTLHSVFF TLKVSILLGS LLGLCLGLEF MGLPNQWARY LRWDASTRSD LSFQFKTNVS TGLLLYLDDG GVCDFLCLSL VDGRVQLRFS MDCAETAVLS NKQVNDSSWH FLMVSRDRLR TVLMLDGEGQ SGELQPQRPY MDVVSDLFLG GVPTDIRPSA LTLDGVQAMP GFKGLILDLK YGNSEPRLLG SRGVQMDAEG PCGERPCENG GICFLLDGHP TCDCSTTGYG GKLCSEDVSQ DPGLSHLMMS EQAREENVAT FRGSEYLCYD LSQNPIQSSS DEITLSFKTW QRNGLILHTG KSADYVNLAL KDGAVSLVIN LGSGAFEAIV EPVNGKFNDN AWHDVKVTRN LRQVTISVDG ILTTTGYTQE DYTMLGSDDF FYVGGSPSTA DLPGSPVSNN FMGCLKEVVY KNNDIRLELS RLARIADTKM KIYGEVVFKC ENVATLDPIN FETPEAYISL PKWNTKRMGS ISFDFRTTEP NGLILFTHGK PQERKDARSQ KNTKVDFFAV ELLDGNLYLL LDMGSGTIKV KATQKKANDG EWYHVDIQRD GRSGTISVNS RRTPFTASGE SEILDLEGDM YLGGLPENRA GLILPTELWT AMLNYGYVGC IRDLFIDGRS KNIRQLAEMQ NAAGVKSSCS RMSAKQCDSY PCKNNAVCKD GWNRFICDCT GTGYWGRTCE REASILSYDG SMYMKIIMPM VMHTEAEDVS FRFMSQRAYG LLVATTSRDS ADTLRLELDG GRVKLMVNLD CIRINCNSSK GPETLYAGQK LNDNEWHTVR VVRRGKSLKL TVDDDVAEGT MVGDHTRLEF HNIETGIMTE KRYISVVPSS FIGHLQSLMF NGLLYIDLCK NGDIDYCELK ARFGLRNIIA DPVTFKTKSS YLSLATLQAY TSMHLFFQFK TTSPDGFILF NSGDGNDFIA VELVKGYIHY VFDLGNGPNV IKGNSDRPLN DNQWHNVVIT RDNSNTHSLK VDTKVVTQVI NGAKNLDLKG DLYMAGLAQG MYSNLPKLVA SRDGFQGCLA SVDLNGRLPD LINDALHRSG QIERGCEGPS TTCQEDSCAN QGVCMQQWEG FTCDCSMTSY SGNQCNDPGA TYIFGKSGGL ILYTWPANDR PSTRSDRLAV GFSTTVKDGI LVRIDSAPGL GDFLQLHIEQ GKIGVVFNIG TVDISIKEER TPVNDGKYHV VRFTRNGGNA TLQVDNWPVN EHYPTGNTDN ERFQMVKQKI PFKYNRPVEE WLQEKGRQLT IFNTQAQIAI GGKDKGRLFQ GQLSGLYYDG LKVLNMAAEN NPNIKINGSV RLVGEVPSIL GTTQTTSMPP EMSTTVMETT TTMATTTTRK NRSTASIQPT SDDLVSSAEC SSDDEDFVEC EPSTDKSLST SIFEGGYKAH APKWESKDFR PNKVSETSRT TTTSLSPELI RFTASSSSGM VPKLPAGKMN NRDLKPQPDI VLLPLPTAYE LDSTKLKSPL ITSPMFRNVP TANPTEPGIR RVPGASEVIR ESSSTTGMVV GIVAAAALCI LILLYAMYKY RNRDEGSYQV DETRNYISNS AQSNGTLMKE KQQSSKSGHK KQKNKDREYY V